Intratympanic dexamethasone as initial therapy for idiopathic sudden sensorineural hearing loss: Clinical evaluation and laboratory investigation

Auris Nasus Larynx

Volumn 38, Issue 2, 2011, Pages 165-171

  Fu, Yaoyao ^a   Zhao, Hui ^a   Zhang, Tianyu ^a   Chi, Fanglu ^a  

^a EYE AND ENT HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Dexamethasone; Inner ear; Sudden sensorineural hearing loss; Tissue distribution

Indexed keywords

CORTICOSTEROID DERIVATIVE; DEXAMETHASONE; OXYGEN; PROSTAGLANDIN E1;

ADULT; ANIMAL EXPERIMENT; ARTICLE; AUDIOGRAPHY; CLINICAL EVALUATION; CONCENTRATION RESPONSE; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; DIZZINESS; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG TISSUE LEVEL; EARDRUM PERFORATION; FEMALE; HUMAN; IDIOPATHIC SUDDEN SENSORINEURAL HEARING LOSS; IMMUNOFLUORESCENCE TEST; INNER EAR; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OTITIS MEDIA; PERCEPTION DEAFNESS; PROGNOSIS; RAT; SPRAGUE DAWLEY RAT; TINNITUS; TREATMENT OUTCOME; VERTIGO;

ALPROSTADIL; ANIMALS; ANTI-INFLAMMATORY AGENTS; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; BIOLOGICAL AVAILABILITY; COMBINED MODALITY THERAPY; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EAR, INNER; EAR, MIDDLE; HEARING LOSS, SUDDEN; HUMANS; HYPERBARIC OXYGENATION; INFUSIONS, INTRAVENOUS; INJECTIONS; METABOLIC CLEARANCE RATE; PROSPECTIVE STUDIES; RATS;

EID: 79151483563     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2010.07.008     Document Type: Article

References (20)

1. Ahn J.H., Han M.W., Kim J.H., Chung J.W., Yoon T.H. Therapeutic effectiveness over time of intratympanic dexamethasone as salvage treatment of sudden deafness. Acta Otolaryngol 2008, 128:128-131.
2. Haynes D.S., O'Malley M., Cohen S., Watford K., Labadie R.F. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2007, 117:3-15.
3. Plaza G., Herraiz C. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy. Otolaryngol Head Neck Surg 2007, 137:74-78.
4. Roebuck J., Chang C.Y. Efficacy of steroid injection on idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2006, 135:276-279.
5. Doyle K.J., Bauch C., Battista R., Beatty C., Hughes G.B., Mason J., et al. Intratympanic steroid treatment: a review. Otol Neurotol 2004, 25:1034-1039.
6. Hamid M., Trune D. Issues, indications, and controversies regarding intratympanic steroid perfusion. Curr Opin Otolaryngol Head Neck Surg 2008, 16:434-440.
7. Chandrasekhar S.S. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 2001, 22:18-23.
8. Canlon B., Meltser I., Johansson P., Tahera Y. Glucocorticoid receptors modulate auditory sensitivity to acoustic trauma. Hear Res 2007, 226:61-69.
9. De Bosscher K., Vanden Berghe W., Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev 2003, 24:488-522.
10. Pondugula S.R., Raveendran N.N., Ergonul Z., Deng Y., Chen J., Sanneman J.D., et al. Glucocorticoid regulation of genes in the amiloride-sensitive sodium transport pathway by semicircular canal duct epithelium of neonatal rat. Physiol Genomics 2006, 24:114-123.
11. Chandrasekhar S.S., Rubinstein R.Y., Kwartler J.A., Gatz M., Connelly P.E., Huang E., et al. Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 2000, 122:521-528.
12. Parnes L.S., Sun A.H., Freeman D.J. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999, 109:1-17.
13. Hargunani C.A., Kempton J.B., DeGagne J.M., Trune D.R. Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form. Otol Neurotol 2006, 27:564-569.
14. Sano H., Okamoto M., Shitara T., Hirayama M. What kind of patients are suitable for evaluating the therapeutic effect of sudden deafness?. Am J Otol 1998, 19:579-583.
15. Kakehata S., Sasaki A., Oji K., Futai K., Ota S., Makinae K., et al. Comparison of intratympanic and intravenous dexamethasone treatment on sudden sensorineural hearing loss with diabetes. Otol Neurotol 2006, 27:604-608.
16. Hong S.M., Park C.H., Lee J.H. Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL. Otolaryng Head Neck 2009, 141:579-583.
17. Ahn J.H., Yoo M.H., Yoon T.H., Chung J.W. Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients with sudden deafness?. Laryngoscope 2008, 118:279-282.
18. Battaglia A., Burchette R., Cueva R. Combination therapy (intratympanic dexamethasone+high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2008, 29:453-460.
19. Plontke S.K., Biegner T., Kammerer B., Delabar U., Salt A.N. Dexamethasone concentration gradients along scala tympani after application to the round window membrane. Otol Neurotol 2008, 29:401-406.
20. Mikulec A.A., Plontke S.K., Hartsock J.J., Salt A.N. Entry of substances into perilymph through the bone of the otic capsule after intratympanic applications in guinea pigs: implications for local drug delivery in humans. Otol Neurotol 2009, 30:131-138.